0001209191-15-058922.txt : 20150702 0001209191-15-058922.hdr.sgml : 20150702 20150702164231 ACCESSION NUMBER: 0001209191-15-058922 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150701 FILED AS OF DATE: 20150702 DATE AS OF CHANGE: 20150702 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHIMERIX INC CENTRAL INDEX KEY: 0001117480 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330903395 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2505 MERIDIAN PARKWAY, SUITE 340 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919.806.1074 MAIL ADDRESS: STREET 1: 2505 MERIDIAN PARKWAY, SUITE 340 CITY: DURHAM STATE: NC ZIP: 27713 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DEMSKI MARTHA J CENTRAL INDEX KEY: 0001198230 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35867 FILM NUMBER: 15970366 MAIL ADDRESS: STREET 1: 9373 TOWNE CENTRE DRIVE SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121-3088 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-07-01 0 0001117480 CHIMERIX INC CMRX 0001198230 DEMSKI MARTHA J C/O CHIMERIX, INC. 2505 MERIDIAN PARKWAY, SUITE 340 DURHAM NC 27713 1 0 0 0 Common Stock 2015-07-01 4 M 0 2000 1.53 A 2000 D Common Stock 2015-07-01 4 S 0 1300 45.70 D 700 D Common Stock 2015-07-01 4 S 0 700 46.63 D 0 D Common Stock 14788 I By the Martha J. Demski Trust u/a 10/01/94 Stock Option (Right to Buy) 1.53 2015-07-01 4 M 0 2000 0.00 D 2018-06-25 Common Stock 2000 7126 D The sales reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the reporting person on September 15, 2014. The range of sale prices received is $45.24 to $46.23. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares sold at each separate price. The range of sale prices received is $46.32 to $46.91. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares sold at each separate price. Immediately exercisable. /s/ Michael Alrutz, Attorney-In-Fact 2015-07-02